100 International, Randomized, Placebo-Controlled Trial Of Cc-486 (Oral Azacitidine) In Patients With Ipss Intermediate-1 Myelodysplastic Syndromes With Rbc-Transfusion-Dependent Anemia And Thrombocytopenia: The Quazar Lower-Risk Mds Trial
AuthID
P-016-QN8
P-016-QN8